Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v4-EN
Language English English
Date Updated 2017-10-11 2017-07-27
Drug Identification Number 02395487 02395487
Brand name TEVA-QUETIAPINE XR TEVA-QUETIAPINE XR
Common or Proper name QUETIAPINE XR QUETIAPINE XR
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients QUETIAPINE QUETIAPINE
Strength(s) 400MG 400MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 60 60
ATC code N05AH N05AH
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-04-15
Actual start date 2017-08-30
Estimated end date 2017-09-29 2017-09-29
Actual end date 2017-10-10
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments